Published in Lab Law Weekly, June 1st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Genetic Technologies.
Report 1: Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to announce the appointment of Dr. Ian Nisbet as Strategic Advisor to the Board. In this role, Dr. Nisbet will be responsible for reviewing the Company's strategic direction and recommending proposals for the exploitation of the Company's assets.
Dr. Nisbet is a distinguished scientist with a PhD in biochemistry from Monash University. His extensive experience in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly